Intra-Cellular Therapies Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2019
Period Ending	Jul '25 Jul 31, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2019
Market Capitalization	423	359	182	257	259	-	Upgrade
Market Cap Growth	118.20%	96.99%	-28.99%	-0.87%	-	-	Upgrade
Enterprise Value	404	354	167	227	255	-	Upgrade
Last Close Price	12.52	12.95	7.44	10.80	12.00	-	Upgrade
PS Ratio	521.02	1666.30	-	-	-	-	Upgrade
PB Ratio	9.02	8.37	16.88	9.19	18.77	-	Upgrade
P/TBV Ratio	8.88	7.37	12.35	8.38	16.69	-	Upgrade
EV/Sales Ratio	-	1641.72	-	-	-	-	Upgrade
Debt / Equity Ratio	0.03	-	-	-	-	-1.22	Upgrade
Asset Turnover	0.02	0.01	-	-	-	-	Upgrade
Quick Ratio	3.79	4.40	3.14	16.46	3.97	0.24	Upgrade
Current Ratio	4.34	4.65	3.71	17.63	4.65	0.26	Upgrade
Return on Equity (ROE)	-128.19%	-42.79%	-94.39%	-61.84%	-173.94%	-523.33%	Upgrade
Return on Assets (ROA)	-59.85%	-61.95%	-57.55%	-38.30%	-41.71%	-109.62%	Upgrade
Return on Capital (ROIC)	-68.49%	-72.35%	-64.31%	-42.49%	-66.39%	-207.37%	Upgrade
Earnings Yield	-9.93%	-2.68%	-9.34%	-4.65%	-3.62%	-	Upgrade
Buyback Yield / Dilution	-26.94%	-3.99%	-7.27%	-73.06%	-11.81%	-39.89%	Upgrade

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.